Clinical trials
Observational Disease Progression trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 7 |
| Completed | 6 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heidelberg University | 2 |
| Heinrich-Heine University, Duesseldorf | 2 |
| Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps | 2 |
| University Hospital Tuebingen | 2 |
| Angel Argiles | 1 |
| Bayer | 1 |
| Biogen | 1 |
| Charite University, Berlin, Germany | 1 |
| Eli Lilly and Company | 1 |
| Friedemann Paul | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease Progression | 22 |
| Multiple Sclerosis | 3 |
| Multiple Sclerosis, Relapsing-Remitting | 2 |
| Pneumonia | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Renal Insufficiency, Chronic | 2 |
| Sepsis | 2 |
| Shock, Septic | 2 |
| Amyloid Neuropathies, Familial | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.